These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 20121482

  • 1. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.
    Srivastava G, Singh K, Tiwari MN, Singh MP.
    Expert Rev Proteomics; 2010 Feb; 7(1):127-39. PubMed ID: 20121482
    [Abstract] [Full Text] [Related]

  • 2. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
    Singh MP, Patel S, Dikshit M, Gupta YK.
    Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
    [Abstract] [Full Text] [Related]

  • 3. Proteomics-driven progress in neurodegeneration research.
    Fountoulakis M, Kossida S.
    Electrophoresis; 2006 Apr; 27(8):1556-73. PubMed ID: 16555340
    [Abstract] [Full Text] [Related]

  • 4. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach.
    Sinha A, Srivastava N, Singh S, Singh AK, Bhushan S, Shukla R, Singh MP.
    Clin Chim Acta; 2009 Feb; 400(1-2):14-20. PubMed ID: 18977210
    [Abstract] [Full Text] [Related]

  • 5. Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.
    Mellick GD, Silburn PA, Sutherland GT, Siebert GA.
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1035-50. PubMed ID: 21080820
    [Abstract] [Full Text] [Related]

  • 6. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T, Carbone DP.
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.
    Zhang X, Yin X, Yu H, Liu X, Yang F, Yao J, Jin H, Yang P.
    Analyst; 2012 Jan 21; 137(2):490-5. PubMed ID: 22108571
    [Abstract] [Full Text] [Related]

  • 9. [Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease].
    da Costa AG, Gago MF, Garrett C.
    Acta Med Port; 2011 Dec 21; 24 Suppl 4():761-8. PubMed ID: 22863482
    [Abstract] [Full Text] [Related]

  • 10. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M, Lopiano L.
    Expert Rev Proteomics; 2008 Apr 21; 5(2):239-48. PubMed ID: 18466054
    [Abstract] [Full Text] [Related]

  • 11. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST.
    Chang Gung Med J; 2008 Apr 21; 31(5):417-30. PubMed ID: 19097588
    [Abstract] [Full Text] [Related]

  • 12. A proteomic approach in the study of an animal model of Parkinson's disease.
    De Iuliis A, Grigoletto J, Recchia A, Giusti P, Arslan P.
    Clin Chim Acta; 2005 Jul 24; 357(2):202-9. PubMed ID: 15946658
    [Abstract] [Full Text] [Related]

  • 13. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL, Blanco-Colio LM, Tunon J, Gomez-Guerrero C, Michel JB, Meilhac O, Egido J.
    Expert Rev Proteomics; 2007 Apr 24; 4(2):249-60. PubMed ID: 17425460
    [Abstract] [Full Text] [Related]

  • 14. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G, Pramanik BN.
    Drug Discov Today; 2009 May 24; 14(9-10):465-71. PubMed ID: 19429505
    [Abstract] [Full Text] [Related]

  • 15. How will haematologists use proteomics?
    Unwin RD, Whetton AD.
    Blood Rev; 2007 Nov 24; 21(6):315-26. PubMed ID: 17889973
    [Abstract] [Full Text] [Related]

  • 16. Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach.
    Chen HM, Lin CY, Wang V.
    Clin Biochem; 2011 Apr 24; 44(5-6):377-85. PubMed ID: 21223953
    [Abstract] [Full Text] [Related]

  • 17. [Proteomics: biomarker research in psychiatry].
    Hünnerkopf R, Grassl J, Thome J.
    Fortschr Neurol Psychiatr; 2007 Oct 24; 75(10):579-86. PubMed ID: 17566964
    [Abstract] [Full Text] [Related]

  • 18. Heredity in Parkinson's disease: new findings.
    Lev N, Melamed E.
    Isr Med Assoc J; 2001 Jun 24; 3(6):435-8. PubMed ID: 11433638
    [Abstract] [Full Text] [Related]

  • 19. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G, de la Cuesta F, Barderas ME, Darde V, Padial LR, Vivanco F.
    Expert Rev Proteomics; 2008 Oct 24; 5(5):679-91. PubMed ID: 18937558
    [Abstract] [Full Text] [Related]

  • 20. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D.
    Neurodegener Dis; 2008 Oct 24; 5(3-4):133-6. PubMed ID: 18322370
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.